Direct answer
Semaglutide selectively targets the GLP-1 receptor. Retatrutide is a triple agonist of GLP-1, GIP and glucagon receptors. They are not interchangeable reference standards and GetReta does not sell semaglutide.
Searches that pair “reta” with Ozempic or Wegovy are mixing a licensed medicine with an investigational research peptide. GetReta listings are the latter only.
Research disclaimer
In stock · UK packed
Free shipping £60
30 mg vial · £2/mg · HPLC ≥99%
Strength 30 mg vial Popular £60 40 mg vial £70
Research injection pen +£5. Optional. The vial is the product. Free tracked UK shipping. Guest checkout. Research use only — not a medicine.
Every vial has a printed lot number – check its CoA